Volume 32, Issue 18 (January 5, 2024)

To see the full issue, subscribers click here.


IBO Stock Indexes in 2023: Declines Reflect an Industry in an Uncertain Position

IBO Stocks Continue Winning Streak

Led by Oil & Gas and Automotive Companies, Worldwide R&D Spending Shows Healthy Growth in Fiscal 2022

Executive Briefing

The latest on Agilent, Bruker, Illumina and more


Third Quarter Results: 10x Genomics, NanoString Technologies and Revvity

Market Profile

Site-Directed Mutagenesis

Industry Watch

Clinical: Medicare Lab Test Spending

Biopharma and Government: US Drug Approvals Increase

Biotech: Stock Turnaround Possible

Region Watch

South Korea: R&D Budget Declines

Japan: R&D Spending Reaches Record High

Poland: R&D Spending Grows in Upper Teens


Broad-Based Companies


Laboratory Products


Laboratory Automation

Sample Preparation

Laboratory Equipment

Bioprocess Analysis

Process Analysis

Bottom Line

Companies’ latest financial results

< | >